Amphetamines are regarded to be metabolized, to some degree, by cytochrome P450 2D6 (CYP2D6) and display minor inhibition of CYP2D6 metabolism; potential for your pharmacokinetic conversation exists with coadministration of CYP2D6 inhibitors which can increase risk with increased exposure to ampheta